Home › Cirrhosis
Cirrhosis clinical trials recruiting in the U.S.
36 studies for Cirrhosis are recruiting participants at sites across the United States.
Cirrhosis is caused when scar tissue replaces healthy tissue in the liver because of chronic injury. Learn how cirrhosis is diagnosed and treated.
Cities with the most studies
- Boston, MA10 studies
- Cleveland, OH9 studies
- Dallas, TX8 studies
- Houston, TX7 studies
- Los Angeles, CA6 studies
- San Antonio, TX6 studies
- New York City, NY5 studies
- Miami, FL5 studies
- Baltimore, MD4 studies
- Chicago, IL4 studies
- Durham, NC4 studies
- San Diego, CA4 studies
- Rochester, MN4 studies
- Nashville, TN3 studies
- Tampa, FL3 studies
- Columbus, OH3 studies
- Indianapolis, IN3 studies
- Philadelphia, PA3 studies
- Richmond, VA3 studies
- Minneapolis, MN3 studies
- Chandler, AZ3 studies
By state
- Arizona5 studies
- California8 studies
- Colorado3 studies
- Florida7 studies
- Georgia3 studies
- Illinois4 studies
- Indiana4 studies
- Maryland4 studies
- Massachusetts10 studies
- Michigan3 studies
- Minnesota7 studies
- Missouri3 studies
- New York6 studies
- North Carolina6 studies
- Ohio12 studies
- Pennsylvania5 studies
- Tennessee5 studies
- Texas13 studies
- Virginia3 studies
Recently updated studies
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT05832229HMB Enriched Amino Acids to Reverse Muscle Loss in Cirrhosis
Recruiting
Ages 21 to 65 · All sexes · Updated Sep 28, 2026 · NCT05166499Molecular Mechanism of Exercise in Cirrhosis
Recruiting
Ages 21 to 65 · All sexes · Updated Sep 28, 2026 · NCT05982769National Liver Cancer Screening Trial
RecruitingPhase 4
Ages 18 to 85 · All sexes · Updated Sep 25, 2026 · NCT06084234A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 23, 2026 · NCT07325526LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06632444Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07610837Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
RecruitingHealthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Aug 21, 2026 · NCT03208868Fibrosis Lessens After Metabolic Surgery
RecruitingPhase 4Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Jul 31, 2026 · NCT06374875Measuring Patient Reported Needs in Outpatient Liver Disease Management
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 29, 2026 · NCT07191886Multi-analyte Blood Test Clinical Trial
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05199259Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05181826High Dose Albumin in Refractory Ascites
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 30, 2026 · NCT05867602Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
Recruiting
Ages 18 and older · All sexes · Updated Jun 25, 2026 · NCT06138821Digoxin In NASH (CODIN)
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated May 26, 2026 · NCT06588699Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant
RecruitingObservational study
Ages 18 to 75 · All sexes · Updated May 7, 2026 · NCT06950788COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT05692024Siemens Biomarker Multi-modality
Recruiting
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT07495332Initial Resuscitation for Acute Kidney Injury in Cirrhosis
Recruiting
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT06525623Transitional Care Program for Fluid Overload in Cirrhosis
Recruiting
Ages 18 and older · All sexes · Updated Mar 9, 2026 · NCT06174272Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Feb 19, 2026 · NCT05526144Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jan 6, 2026 · NCT06526104A Study of SIPLIZUMAB in AILD and LT Patients
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 24, 2025 · NCT06455280The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2025 · NCT06871111Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
RecruitingObservational study
Ages 18 to 80 · All sexes · Updated Oct 20, 2025 · NCT04613921From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.